These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

136 related articles for article (PubMed ID: 10759266)

  • 1. The outcome of pregnancy in Kell alloimmunisation.
    Grant SR; Kilby MD; Meer L; Weaver JB; Gabra GS; Whittle MJ
    BJOG; 2000 Apr; 107(4):481-5. PubMed ID: 10759266
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Relationship between maternal antibody type and antenatal course following intrauterine transfusion for red cell alloimmunisation.
    Walsh CA; Russell N; McAuliffe FM; Higgins S; Mahony R; Carroll S; McParland P
    Eur J Obstet Gynecol Reprod Biol; 2013 Dec; 171(2):235-9. PubMed ID: 24075591
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The significance of anti-Kell sensitization in pregnancy.
    Mayne KM; Bowell PJ; Pratt GA
    Clin Lab Haematol; 1990; 12(4):379-85. PubMed ID: 2081378
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pregnancy outcome in mothers who develop Kell antibodies.
    Farr V; Gray E
    Scott Med J; 1988 Aug; 33(4):300-3. PubMed ID: 3055288
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Obstetric history and antibody titer in estimating severity of Kell alloimmunization in pregnancy.
    van Wamelen DJ; Klumper FJ; de Haas M; Meerman RH; van Kamp IL; Oepkes D
    Obstet Gynecol; 2007 May; 109(5):1093-8. PubMed ID: 17470588
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Predicting anti-Kell-mediated hemolytic disease of the fetus and newborn: diagnostic accuracy of laboratory management.
    Slootweg YM; Lindenburg IT; Koelewijn JM; Van Kamp IL; Oepkes D; De Haas M
    Am J Obstet Gynecol; 2018 Oct; 219(4):393.e1-393.e8. PubMed ID: 30063902
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Decreased fetal erythropoiesis and hemolysis in Kell hemolytic anemia.
    Weiner CP; Widness JA
    Am J Obstet Gynecol; 1996 Feb; 174(2):547-51. PubMed ID: 8623782
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Maternal Kell blood group alloimmunization.
    Bowman JM; Pollock JM; Manning FA; Harman CR; Menticoglou S
    Obstet Gynecol; 1992 Feb; 79(2):239-44. PubMed ID: 1731292
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Kell alloimmunization in pregnancy: associated with fetal thrombocytopenia?
    van den Akker ES; Klumper FJ; Brand A; Kanhai HH; Oepkes D
    Vox Sang; 2008 Jul; 95(1):66-9. PubMed ID: 18435678
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prevalence and obstetric outcome of women with red cell antibodies in pregnancy at the Leeds Teaching Hospitals NHS Trust, West Yorkshire, England.
    Awowole I; Cohen K; Rock J; Sparey C
    Eur J Obstet Gynecol Reprod Biol; 2019 Jun; 237():89-92. PubMed ID: 31035121
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Current clinical management of anti-Kell alloimmunization in pregnancy.
    Santiago JC; Ramos-Corpas D; Oyonarte S; Montoya F
    Eur J Obstet Gynecol Reprod Biol; 2008 Feb; 136(2):151-4. PubMed ID: 17481801
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Management of pregnancies complicated by anti-Kell isoimmunization.
    McKenna DS; Nagaraja HN; O'Shaughnessy R
    Obstet Gynecol; 1999 May; 93(5 Pt 1):667-73. PubMed ID: 10912964
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Anti-Kell in pregnancy.
    Leggat HM; Gibson JM; Barron SL; Reid MM
    Br J Obstet Gynaecol; 1991 Feb; 98(2):162-5. PubMed ID: 2004052
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Erythropoietic suppression in fetal anemia because of Kell alloimmunization.
    Vaughan JI; Warwick R; Letsky E; Nicolini U; Rodeck CH; Fisk NM
    Am J Obstet Gynecol; 1994 Jul; 171(1):247-52. PubMed ID: 8030708
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Kell alloimmunization in pregnancy].
    Gariod S; Brossard Y; Poissonnier MH; Vuilliez B; Deutsch V; Jouk PS; Pons JC
    J Gynecol Obstet Biol Reprod (Paris); 2004 Nov; 33(7):637-48. PubMed ID: 15550883
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Status of Kell incompatibility in a 15-year retrospective study of mother-child serology in clinical records].
    Schönitzer D
    Infusionsther Klin Ernahr; 1987 Apr; 14 Suppl 2():3-9. PubMed ID: 3596796
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Obstetric outcome after RhD and Kell testing.
    Lipitz S; Many A; Mitrani-Rosenbaum S; Carp H; Frenkel Y; Achiron R
    Hum Reprod; 1998 Jun; 13(6):1472-5. PubMed ID: 9688374
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prognostic factors and management in pregnancies complicated with severe kell alloimmunization: experiences of the last 13 years.
    Babinszki A; Lapinski RH; Berkowitz RL
    Am J Perinatol; 1998; 15(12):695-701. PubMed ID: 10333397
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Follow-up of pregnancies with red-cell allo-immunisation: State-of-the art].
    Carbonne B; Castaigne V; Cynober E; Levy R; Cortey A; Mailloux A; Larsen M; Brossard Y
    Gynecol Obstet Fertil; 2010 Mar; 38(3):205-13. PubMed ID: 20207183
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The clinical outcome of non-RhD antibody affected pregnancies in Northern Ireland.
    Chandrasekar A; Morris KG; Tubman TR; Tharma S; McClelland WM
    Ulster Med J; 2001 Nov; 70(2):89-94. PubMed ID: 11795772
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.